Quest Diagnostics (DGX) Return on Capital Employed (2009 - 2026)
Quest Diagnostics (DGX) posted Return on Capital Employed of 10.85% for Q2 2026, down 3.73% sequentially from 11.27% in Q1 2026, and up 21.0% YoY from 8.97% in Q2 2025.
Quest Diagnostics (DGX) Return on Capital Employed (2009 - 2026) Analysis & Trends
Quest Diagnostics has reported Return on Capital Employed for 18 years, with the latest figure at 10.85% in Q2 2026.
- Quarterly Return on Capital Employed rose 21.0% year-over-year to 10.85% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 10.85% (up 21.0% YoY) and the FY2025 annual result came in at 11.19%, up 77.0% from the prior year.
- Return on Capital Employed slipped to 10.85% in Q2 2026 per DGX's latest filing, from 11.27% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 18.89% in Q1 2022 and troughed at 9.55% in Q3 2023.
- A 5-year average of 11.73% and a median of 10.7% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed tumbled 824 bps in 2023, then jumped 170 bps in 2026.
- Over 5 years, Return on Capital Employed stood at 12.44% in 2022, then fell by 15 bps to 10.57% in 2023, then fell by 9 bps to 9.65% in 2024, then rose by 16 bps to 11.17% in 2025, then fell by 3 bps to 10.85% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 10.85%, 11.27%, and 11.17% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 10.85% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 8.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.85% |
| Mar 31, 2026 | 11.27% |
| Dec 31, 2025 | 11.17% |
| Sep 30, 2025 | 10.98% |
| Jun 30, 2025 | 10.64% |
| Mar 31, 2025 | 9.58% |
| Dec 31, 2024 | 9.65% |
| Sep 30, 2024 | 9.71% |
| Jun 30, 2024 | 10.62% |
| Mar 31, 2024 | 10.75% |
| Dec 31, 2023 | 10.57% |
| Sep 30, 2023 | 9.55% |
| Jun 30, 2023 | 10.50% |
| Mar 31, 2023 | 10.65% |
| Dec 31, 2022 | 12.44% |
| Sep 30, 2022 | 15.68% |
| Jun 30, 2022 | 17.70% |
| Mar 31, 2022 | 18.89% |
| Dec 31, 2021 | 20.11% |
| Sep 30, 2021 | 23.04% |